Sandoz to build biosimilar technical development center in SloveniaSandoz will invest roughly $90 million to build a state-of-the-art Sandoz Biosimilar Technical Development Center in Ljubljana, Slovenia, by 2026. Aurobindo receives FDA OK for 2 genericsAurobindo has received the FDA's nod for generic Steglatro and generic Otezla. Teva, Alvotech expand biosimilars partnership agreement Teva will exclusively commercialize two new biosimilar candidates and two line extensions of current biosimilars in the U.S., developed and manufactured by Alvotech. Camber intros generic Noxafil The tablets are indicated for the prophylaxis of invasive Aspergillus and Candida infections in severely immunocompromised patients. Natco obtains FDA nod for generic Lonsurf Generic Lonsurf is indicated primarily for the treatment of colorectal cancer. Dr. Reddy’s proposed Rituximab biosimilar application accepted for review by FDA, EMA and MHRA Rituxan/MabThera is approved for various indications. Lupin receives FDA nod for generic chlorpromazine hydrochloride Chlorpromazine hydrochloride is used to treat certain mental health disorders. Cosette debuts generic Aczone Dapsone 5% gel is used to treat acne. Aurobindo receives FDA OK for generic Renagel Sevelamer hydrochloride tablets are indicated for the control of serum phosphorus in patients with chronic kidney disease on dialysis. Aurobindo receives FDA nod for generic Rozerem Ramelteon tablets are indicated as a treatment for insomnia characterized by difficulty with sleep onset. First Previous 60 61 62 63 64 Next Last
